(Acticin)
4,997 results
  • Delayed-Onset and Prolonged Laryngeal Edema Following Pyrethroid Insecticide Poisoning: A Case Report. [Case Reports]
    Cureus. 2026 Apr; 18(4):e107257.Hasunuma K, Toida C, … Imamura HC
  • Pyrethroid insecticides are generally considered to have low mammalian toxicity; however, severe toxicity may occur following high-dose or intentional ingestion. Pyrethroids are classified into two types, Type Ⅰ and Type Ⅱ, with permethrin belonging to Type Ⅰ, which is typically associated with tremor. Laryngeal edema associated with pyrethroid poisoning has been rarely reported and is usually ac…
  • Commercial permethrin elicits chemoreceptive responses on different Anopheles gambiae sensory appendages. [Journal Article]
    Pest Manag Sci. 2026 May 11. [Online ahead of print]Kambou SS, Valente A, … Carrasco DPM
  • CONCLUSIONS: These findings indicate that An. gambiae detects commercial permethrin in vapor form using two distinct sensory appendages: the tarsi and the antennae, but with varying behavioral output. The results suggest that the non-contact detection of the insecticide may be mediated by chemosensory signaling pathways. Nonetheless, further research is required to identify the specific sensory mechanisms involved in the detection of pyrethroids in malaria mosquitoes, and their contribution to the evolution of behavioral adaptations against pyrethroid-based vector control tools. © 2026 The Author(s). Pest Management Science published by John Wiley & Sons Ltd on behalf of Society of Chemical Industry.
  • Combined Oral Ivermectin and 5% Permethrin Cream to Treat Severe Scabies. [Randomized Controlled Trial]
    N Engl J Med. 2026 May 07; 394(18):1814-1823.Bernigaud C, Do-Pham G, … Chosidow ONEJM
  • CONCLUSIONS: Among adults, the 400-μg-per-kilogram dose of ivermectin plus 5% permethrin cream was not superior to the standard 200-μg-per-kilogram dose of ivermectin plus 5% permethrin cream in curing severe scabies. (Funded by the French Ministry of Health and French Society of Dermatology; ClinicalTrials.gov number, NCT02841215.).